Eucomed MTF 2011: the medical technology renaissance - the pain of rebirth into the value-led age
This article was originally published in Clinica
"Evolution not revolution" may be the phrase used by the European Commission to describe forthcoming regulatory changes, but when it comes to technical advances, it is clear that a revolution is needed in how medical technology serves patient needs and in how it can be afforded.
You may also be interested in...
February sees some vitally important issues on the European Commission’s agenda, including areas where the medtech sector has been clamoring for progress in terms of clarity over the Commission's thinking and guidance documents. This year's meetings are plentiful and critical.
While the EU has selected the CND system as the basis for its nomenclature, GMDN is becoming increasingly valued on the US and international scene. How does it see its latest role panning out globally?
Updated medtech notified body figures from the European Commission always make headline news. But industry needs to see real appointments now, not a list of tricky-to-understand numbers.